Division of Hematology-Oncology,
Beth Israel Deaconess Medical Center,
Department of Medicine,
Division of Hematology-Oncology, Beth Israel Deaconess Medical Center,
Department of Medicine, Beth Israel Deaconess Medical Center
Vassiliki A. Boussiotis has not added Biography.
If you are Vassiliki A. Boussiotis and would like to personalize this page please email our Author Liaison for assistance.
CTLA-4 regulates cell cycle progression during a primary immune response.
European journal of immunology 02, 2002 | Pubmed ID: 11807776
Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses.
Blood Feb, 2002 | Pubmed ID: 11830501
CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Journal of immunology (Baltimore, Md. : 1950) Mar, 2002 | Pubmed ID: 11884439
Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia.
Proceedings of the National Academy of Sciences of the United States of America May, 2002 | Pubmed ID: 12032325
IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL.
Blood Mar, 2004 | Pubmed ID: 14615384
Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
The Journal of experimental medicine Sep, 2004 | Pubmed ID: 15353558
RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion.
Developmental cell Oct, 2004 | Pubmed ID: 15469846
Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia.
Haematologica Dec, 2004 | Pubmed ID: 15590396
CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy.
Blood Nov, 2005 | Pubmed ID: 16020508
Rap1-GTP is a negative regulator of Th cell function and promotes the generation of CD4+CD103+ regulatory T cells in vivo.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2005 | Pubmed ID: 16116203
Rap1 regulation of RIAM and cell adhesion.
Methods in enzymology , 2006 | Pubmed ID: 16757337
CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
Cell cycle (Georgetown, Tex.) Sep, 2006 | Pubmed ID: 16969077
Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications.
Journal of molecular medicine (Berlin, Germany) Nov, 2006 | Pubmed ID: 16972086
A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
Nature immunology Nov, 2006 | Pubmed ID: 17013388
Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-beta signaling in activated T lymphocytes.
Blood Apr, 2007 | Pubmed ID: 17164348
Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.
Clinical immunology (Orlando, Fla.) Jun, 2008 | Pubmed ID: 18395491
CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation May, 2008 | Pubmed ID: 18410894
Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.
Leukemia Jan, 2009 | Pubmed ID: 18596736
Control and regulation of peripheral tolerance in allergic inflammatory disease: therapeutic consequences.
Chemical immunology and allergy , 2008 | Pubmed ID: 18802347
The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells.
Proceedings of the National Academy of Sciences of the United States of America Dec, 2008 | Pubmed ID: 19073936
Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression.
Cell cycle (Georgetown, Tex.) Apr, 2009 | Pubmed ID: 19270514
The cyclin dependent kinase inhibitor (R)-roscovitine prevents alloreactive T cell clonal expansion and protects against acute GvHD.
Cell cycle (Georgetown, Tex.) Jun, 2009 | Pubmed ID: 19448431
RIAM regulates the cytoskeletal distribution and activation of PLC-gamma1 in T cells.
Science signaling Dec, 2009 | Pubmed ID: 19952372
IL-1β-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells.
Journal of immunology (Baltimore, Md. : 1950) Oct, 2010 | Pubmed ID: 20817874
Rap1A regulates generation of T regulatory cells via LFA-1-dependent and LFA-1-independent mechanisms.
Cellular immunology , 2010 | Pubmed ID: 20864093
Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells.
The Journal of biological chemistry May, 2011 | Pubmed ID: 21454517
Molecular and functional heterogeneity of T regulatory cells.
Clinical immunology (Orlando, Fla.) Dec, 2011 | Pubmed ID: 21945485
Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation.
Science signaling Jun, 2012 | Pubmed ID: 22740686
Runx1 and Runx3 are involved in the generation and function of highly suppressive IL-17-producing T regulatory cells.
PloS one , 2012 | Pubmed ID: 22984619
PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.
Cell cycle (Georgetown, Tex.) Dec, 2012 | Pubmed ID: 23032366
Rap1-interacting adapter molecule (RIAM) associates with the plasma membrane via a proximity detector.
The Journal of cell biology Oct, 2012 | Pubmed ID: 23045549
RIAM (Rap1-interacting adaptor molecule) regulates complement-dependent phagocytosis.
Cellular and molecular life sciences : CMLS Jul, 2013 | Pubmed ID: 23420480
PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2.
Molecular and cellular biology Aug, 2013 | Pubmed ID: 23732914
The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer.
Clinical immunology (Orlando, Fla.) Aug, 2013 | Pubmed ID: 23773923
The cyclin dependent kinase inhibitor (R)-roscovitine mediates selective suppression of alloreactive human T cells but preserves pathogen-specific and leukemia-specific effectors.
Clinical immunology (Orlando, Fla.) May-Jun, 2014 | Pubmed ID: 24631965
Biochemical signaling of PD-1 on T cells and its functional implications.
Cancer journal (Sudbury, Mass.) Jul-Aug, 2014 | Pubmed ID: 25098287
The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation.
Blood Nov, 2014 | Pubmed ID: 25287708
Somatic mutations and immunotherapy outcome with CTLA-4 blockade in melanoma.
The New England journal of medicine Dec, 2014 | Pubmed ID: 25409261
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation.
Nature communications Mar, 2015 | Pubmed ID: 25809635
Cell-specific PD-L1 expression in DLBCL.
Blood Nov, 2015 | Pubmed ID: 26542250
Regulation of T Cell Differentiation and Function by EZH2.
Frontiers in immunology , 2016 | Pubmed ID: 27199994
Clinical significance of T cell metabolic reprogramming in cancer.
Clinical and translational medicine Dec, 2016 | Pubmed ID: 27510264
Corrigendum: Regulation of T Cell Differentiation and Function by EZH2.
Frontiers in immunology , 2016 | Pubmed ID: 27648006
Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 01, 2017 | Pubmed ID: 27777141
Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
Oncotarget Dec, 2016 | Pubmed ID: 27793053
The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation.
Frontiers in immunology , 2016 | Pubmed ID: 28018338
The role of metabolic reprogramming in T cell fate and function.
Current trends in immunology , 2016 | Pubmed ID: 28356677
Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses.
Frontiers in immunology , 2017 | Pubmed ID: 28443090
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies.
Blood and lymphatic cancer : targets and therapy , 2017 | Pubmed ID: 28701859
The adaptor molecule RIAM integrates signaling events critical for integrin-mediated control of immune function and cancer progression.
Science signaling Aug, 2017 | Pubmed ID: 28831022
JAK3-mediated phosphorylation of EZH2: a novel mechanism of non-canonical EZH2 activation and oncogenic function.
Translational cancer research Nov, 2016 | Pubmed ID: 28868240
Feeling stressed? It might be your T cells.
Nature immunology Nov, 2017 | Pubmed ID: 29144505
Immunotherapies for malignant glioma.
Oncogene Mar, 2018 | Pubmed ID: 29242608
Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor.
Blood advances Jun, 2018 | Pubmed ID: 29898877
Publisher Correction: Feeling stressed? It might be your T cells.
Nature immunology Sep, 2018 | Pubmed ID: 29955108
Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy.
Frontiers in oncology , 2018 | Pubmed ID: 30123774
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved